Download the Rigomo App for the Best Learning Experience!. Download Now

Published - Fri, 22 Jul 2022

URINARY TRACT INFECTIONS (UTIs)

URINARY TRACT INFECTIONS (UTIs)

Urinary tract infections (UTIs) are commonly evaluated in the emergency department (ED). Most UTIs are caused by pathogens that normally inhabit the perineum and gastrointestinal tract.

80-90% to one hundred percent of UTIs are caused by Escherichia coli.

Klebsiella, Proteus, Enterobacter, and Pseudomonas species account for 10% to 20% of cases.

Group D Streptococcus, Chlamydia, and Staphylococcus are responsible in fewer than 5% of cases.



Predisposing factors:

Women are affected more often than men because the shorter female urethra facilitates bacterial access to the bladder.

a) Sexual intercourse and the use of nonoxynol-9–containing spermicides predispose to the development of UTIs.

b) A significant frequency of asymptomatic bacteriuria is linked to pregnancy.

c) Postmenopausal state

d) Immunosuppression


Men

a) Predisposing conditions (e.g., anatomic abnormalities, tumors, calculi, prostatitis, and enlarged prostate) are found in up to 80% of men with UTIs.

b) Many male UTI cases are caused by catheterization.

c) Uncircumcised men (and women who have intercourse with uncircumcised men) are more prone to UTIs.

d) Immunosuppression



Clinical features:

Symptoms: Presenting symptoms may include urinary urgency, frequency, nocturia, dysuria, a sensation of incomplete voiding, and suprapubic pain. Patients with upper tract involvement may also have fever, chills, nausea, and vomiting.

Physical examination findings: Flank pain, mild suprapubic midline tenderness, and costovertebral angle tenderness may be associated with pyelonephritis and cystitis.



Differential diagnoses:

—Vaginitis resulting from Candida albicans, Trichomonas vaginalis, or Gardnerella infection must be considered.

—When males appear with urethral discharge, urethritis is a crucial factor to take into account. Neisseria gonorrhoeae and Chlamydia trachomatis are the most prevalent pathogens.

Prostatitis: The most common infecting organisms are E. coli (80% of cases), Pseudomonas, Klebsiella, Proteus, and Enterococcus. 



Evaluation:

1).Urinalysis should be performed on a midstream clean-catch specimen. Patients with certain clinical conditions (e.g., vaginal discharge, vaginal bleeding, obesity) may need to be catheterized to obtain a urine specimen.

a) Microscopic analysis: 

Hematuria could be an indication of upper or lower tract involvement.

Bacteriuria: More than 10 to 15 organisms per high-power field on a centrifuged specimen is suggestive of UTI. Finding any bacteria on an uncentrifuged specimen correlates with a positive urine culture.

Pyuria is defined by the presence of more than 10 white blood cells (WBCs) per high-power field.


b) Dipstick analysis:

Leukocyte esterase test: The leukocyte esterase test is a reliable screen for pyuria, although false-negative results may occur with low-level pyuria.

The presence of nitrites is a sign of gram-negative bacterial infection.


2). Urine cultures:

a) Indications: Urine cultures are not routinely ordered on uncomplicated infections but may be indicated in some patients. Examples include immunosuppressed patients, suspected pyelonephritis, indwelling catheters, patients who fail to respond to therapy, patients requiring hospitalization, or a history of drug-resistant infections.

b) Interpretation: A positive culture is one where 105 colonies/mL of urine are growing.


3). Complete blood count (CBC): The CBC may reveal leukocytosis in patients with suspected pyelonephritis. The leukocyte count is not generally elevated or indicated in patients with only cystitis.



Therapy:

1). Cystitis:

—Uncomplicated cases: In patients without constitutional symptoms or complicating medical conditions and a short duration of symptoms, uncomplicated cystitis can be treated with a 5-day course of nitrofurantoin, or a 3-day course of oral trimethoprim–sulfamethoxazole.

—Complicated cases: In patients with complicating medical conditions, a longer duration of symptoms, or a relapse of infection, 7 to 10 days of therapy is required.

—Pregnant patients: Uncomplicated cystitis and asymptomatic bacteriuria in pregnant women can be treated with oral amoxicillin, nitrofurantoin, or cefpodoxime.


2). Pyelonephritis:

a) Outpatient treatment

Parenteral antibiotics should be given before discharge. Ceftriaxone (1–2 g) or gentamicin (1.0 mg/kg) with ampicillin (1–2 g).

—Oral antibiotics: A 10- to 14-day course of trimethoprim–sulfamethoxazole (160/800 mg, twice daily by mouth) or a fluoroquinolone (e.g., ciprofloxacin, 500 mg twice daily) is required. Nitrofurantoin shouldn't be used to treat pyelonephritis.

b)Inpatient management entails the intravenous administration of the Parenteral antibiotics [Ceftriaxone (1–2 g) or gentamicin (1.0 mg/kg) with ampicillin (1–2 g)], or aztreonam (0.5–2 g two to four times daily), imipenem (600 mg three to four times daily), or ciprofloxacin (200–400 mg intravenously twice daily).



Disposition:

Patients who need to be admitted to the hospital include:

—Those with clinical toxicity (e.g., fever, vomiting, ill-appearing)

—Those who are unable to take oral fluids or drugs..

—Patients with pyelonephritis who are very young, pregnant, or elderly


Discharge: Most patients are treated as outpatients. Before discharge, patients should be advised regarding the prevention of UTIs. There are several widely used strategies for preventing UTIs:

—Practicing postcoital voiding

—Urinating frequently and completely;

—Increasing fluid intake 

—Observing regional hygiene (including wiping from front to back)

Created by

Rigomo Team

Rigomo is a leading online education platform that offers a wide range of courses to help individuals enhance their skills and achieve their career goals. With our user-friendly interface and expert instructors, we strive to provide high-quality education to everyone, anytime and anywhere. Join us today and take the first step towards a brighter future.

Rigomo is an e-learning platform that was founded in 2019 by a team of dedicated professionals with a passion for revolutionizing the way people learn. The platform offers a range of online courses that cover various industries, including business, technology, healthcare, and more.

Rigomo's courses are designed to be interactive and engaging, with a focus on practical skills that learners can apply in their careers. The platform uses a combination of video lectures, quizzes, and hands-on projects to help learners master the subject matter.

Rigomo is committed to providing affordable and accessible education to people around the world. The platform offers a range of pricing options, including monthly and annual subscriptions, as well as pay-as-you-go options for individual courses.

Since its launch, Rigomo has received numerous accolades for its innovative approach to e-learning. The platform has helped thousands of learners across the globe acquire new skills and advance their careers.

As Rigomo continues to grow, the team remains committed to providing high-quality education that is accessible to all. The platform is constantly updating its courses and features to ensure that learners have access to the latest tools and technologies.

View profile

Comments (0)

Search
Popular categories
Latest blogs
Transforming Emergency Care: The Story Behind Rigomo's Revolutionary PPMMP Course
Transforming Emergency Care: The Story Behind Rigomo's Revolutionary PPMMP Course
In the bustling corridors of a major hospital in Mumbai, Dr. Ayesha Khan felt the pulse of emergency medicine beating at a frantic pace. As a seasoned emergency room physician, she had seen it all — from the heartbreaking to the miraculous. Yet, despite her years of experience, Dr. Khan often felt that something was missing — a gap between the theoretical knowledge she had acquired and the real-world application of managing complex patient scenarios. It was during one critical incident, a complicated case of a diabetic emergency with multiple complications, that the idea for a comprehensive training program began to take shape.Dr. Khan observed that while her team was highly educated, they often hesitated, unsure of the best course of action when standard procedures didn’t align perfectly with the complexities presented by real-life cases. This observation was the seed that grew into the Practical Patient Management Program (PPMMP), developed in collaboration with Rigomo, a pioneer in healthcare education.The Genesis of PPMMPThe journey began with a simple question: How could healthcare professionals bridge the gap between theoretical learning and practical execution? The answer lay in creating a dynamic, interactive, and comprehensive training environment that mirrored real-life medical emergencies more closely than traditional classrooms or online courses ever could.Dr. Khan approached Rigomo with her vision, and together, they crafted a curriculum that was deeply rooted in the realities of medical practice. They decided to focus on a multi-faceted approach, incorporating simulations of emergency scenarios, step-by-step analytical techniques, and patient management strategies under pressure.What Sets PPMMP Apart?From the outset, the PPMMP was designed to be different. It wasn’t just about learning what to do; it was about understanding why, how, and when to do it. The course covers a wide range of emergencies — from metabolic crises like diabetes to respiratory emergencies and anaphylaxis. Each module is built around the latest research and clinical guidelines, ensuring that participants receive the most up-to-date information possible.However, the real magic of the PPMMP lies in its delivery. Recognizing the linguistic diversity of India, the entire course is offered in Hindi, making it accessible to a broader range of healthcare professionals. This decision has democratized access to advanced medical training, particularly benefiting those in rural or underserved areas.A Real-World ImpactOne of the most compelling testimonials comes from Dr. Manav Arora, a young doctor who enrolled in the PPMMP shortly after its launch. During an overnight shift, Dr. Arora faced a severe case of pulmonary embolism — a situation he had only read about in textbooks. Armed with knowledge and hands-on practice from the PPMMP, he was able to lead his team effectively, administer the right interventions, and save a life that night. Dr. Arora credits the PPMMP for his confidence and quick decision-making skills.Looking AheadToday, the PPMMP is not just a course but a movement. It’s about empowering doctors, nurses, and paramedics with the confidence to take bold, informed actions in critical situations. As healthcare continues to evolve, Rigomo is committed to updating the curriculum to include new findings, techniques, and technologies.The success story of the PPMMP is a testament to the power of innovative thinking in education and the profound impact it can have on healthcare delivery. It stands as a beacon for future endeavors in medical training, highlighting the crucial link between knowledge and action in saving lives.The Practical Patient Management Program has grown significantly since its inception, touching the lives of numerous healthcare professionals across India. The course’s success has encouraged other institutions to look towards similar models of integrated, practical training programs. To learn more about the PPMMP or to enroll in this transformative course, please visit PPMMP at Rigomo https://ppmp.rigomo.com. By joining this program, you not only gain access to advanced medical training but also become part of a community dedicated to excellence in healthcare services. The platform’s easy-to-navigate interface and comprehensive resources ensure that every participant can maximize their learning potential and truly make a difference in their professional environments.

Sun, 12 May 2024

Empowering Rural Healthcare: How Pogiko's AI is Bridging the Gap in Medical Services
Empowering Rural Healthcare: How Pogiko's AI is Bridging the Gap in Medical Services
Access to quality healthcare remains a significant challenge in rural regions, where the scarcity of medical resources and professionals exacerbates health disparities. Pogiko, an innovative AI-powered tool from Rigomo Technologies, is emerging as a transformative solution to these challenges. This article delves deeper into how Pogiko is enhancing healthcare delivery in underserved areas.Technological Innovation Meets Rural Medicine Pogiko utilizes advanced AI algorithms to perform functions like disease diagnosis, medical report analysis, and case management, traditionally reserved for specialists in well-equipped urban centers. By automating these complex tasks, Pogiko provides rural doctors with the capabilities of a virtual specialist team, enabling them to offer comprehensive medical care even in resource-limited settings.Immediate Benefits of AI in Rural HealthcareEnhanced Diagnostic Accuracy: Pogiko's AI quickly interprets symptoms and medical data, providing accurate diagnostics that are crucial in areas where specialist consultation is rare or delayed.Decision Support: It offers real-time decision support to healthcare providers, aiding them in treatment planning and management, thus minimizing the risks associated with delayed care.Education and Training: Through regular updates and learning tools, Pogiko keeps rural healthcare providers abreast of the latest medical advancements and treatment protocols, significantly improving their knowledge base without the need for frequent travel for training.Case Management and Remote Assistance With Pogiko, rural healthcare practitioners can manage multiple cases efficiently, with AI suggesting the most effective treatment plans based on the latest guidelines and patient data. Additionally, its ability to facilitate remote consultations helps bridge the distance between rural practitioners and specialists in urban centers, fostering a collaborative approach to patient care.Long-Term Impact and Scalability The scalability of AI tools like Pogiko promises a broader reach, potentially transforming healthcare delivery in remote areas globally. By providing high-quality medical advice and support, Pogiko helps reduce healthcare inequalities, ensuring that rural populations have better health outcomes and access to advanced care practices.Pogiko exemplifies how AI can play a pivotal role in not just supporting but significantly enhancing healthcare in rural areas. As technology advances, the potential for AI to serve as a cornerstone in rural healthcare systems becomes increasingly evident, offering a beacon of hope for regions still struggling with the basics of medical care.

Thu, 25 Apr 2024

Advancements in the Treatment of Pulmonary Embolism: What's New in 2024?
Advancements in the Treatment of Pulmonary Embolism: What's New in 2024?
Artificial Intelligence in DiagnosisAdvancements in Endovascular TherapiesPersonalized Treatment ApproachesNew Pharmacological TreatmentsMultidisciplinary Care TeamsThe landscape of pulmonary embolism treatment in 2024 is characterized by rapid advancements in technology, personalized medical approaches, and the development of safer, more effective therapies. These innovations not only improve the quality of care received by patients but also significantly increase survival rates and enhance the quality of life following a PE diagnosis. As research continues and technologies evolve, we can expect even more impressive strides in the treatment of this challenging condition.

Wed, 24 Apr 2024

All blogs